(CRH) CRH - Overview
Sector: Basic Materials | Industry: Building Materials | Exchange: NYSE (USA) | Market Cap: 69.015m USD | Total Return: 17.5% in 12m
Stock
Building Materials, Aggregates, Cement, Concrete, Infrastructure
Total Rating 50
Risk 93
Buy Signal -0.79
Market Cap:
69,015m
Avg Trading Vol: 615M USD
Avg Trading Vol: 615M USD
ATR:
3.58%
Peers RS (IBD): 43.3
Peers RS (IBD): 43.3
Risk 5d forecast
Volatility34.2%
Rel. Tail Risk-3.71%
Reward TTM
Sharpe Ratio0.52
Alpha-4.43
Character TTM
Beta1.460
Beta Downside1.136
Drawdowns 3y
Max DD27.01%
CAGR/Max DD1.06
Description: CRH CRH
March 05, 2026
CRH plc is a global building materials company. It provides materials and solutions for public infrastructure, commercial, and residential construction.
The company operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. This structure highlights a strategic focus on the North American market for both raw materials and finished building products. The construction materials sector is cyclical, influenced by economic growth and interest rates.
CRHs product offerings include aggregates, cement, ready-mixed concrete, asphalt, and precast concrete products like pipes and manholes. They also supply specialized materials for critical utility infrastructure (water, energy, telecommunications) and outdoor living spaces. Further research on ValueRay can provide detailed financials and competitive analysis to assess CRHs market position.
The company also produces and supplies crushed stone, sand, gravel, and various concrete products such as pavers, blocks, and retaining walls. These products are fundamental to both new construction and maintenance projects across diverse end-markets.
- Infrastructure spending boosts demand for construction materials
- Raw material costs impact profit margins
- Regulatory changes affect environmental compliance expenses
- Housing market trends influence building product sales
Piotroski VR‑10 (Strict, 0-10)
7.5
| Net Income: 4.58b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.33 > 1.0 |
| NWC/Revenue: 13.22% < 20% (prev 11.06%; Δ 2.15% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.62b > Net Income 4.58b |
| Net Debt (15.61b) to EBITDA (9.69b): 1.61 < 3 |
| Current Ratio: 1.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (673.1m) vs 12m ago -1.55% < -2% |
| Gross Margin: 35.62% > 18% (prev 0.36%; Δ 3.53k% > 0.5%) |
| Asset Turnover: 91.75% > 50% (prev 67.63%; Δ 24.13% > 0%) |
| Interest Coverage Ratio: 6.28 > 6 (EBITDA TTM 9.69b / Interest Expense TTM 1.07b) |
Altman Z''
3.82
| A: 0.11 (Total Current Assets 15.25b - Total Current Liabilities 8.75b) / Total Assets 58.33b |
| B: 0.44 (Retained Earnings 25.59b / Total Assets 58.33b) |
| C: 0.12 (EBIT TTM 6.69b / Avg Total Assets 53.60b) |
| D: 0.78 (Book Value of Equity 25.62b / Total Liabilities 32.85b) |
| Altman-Z'' Score: 3.82 = AA |
Beneish M
-2.94
| DSRI: 0.67 (Receivables 4.64b/4.65b, Revenue 49.18b/33.05b) |
| GMI: 1.00 (GM 35.62% / 35.67%) |
| AQI: 1.05 (AQ_t 0.29 / AQ_t-1 0.27) |
| SGI: 1.49 (Revenue 49.18b / 33.05b) |
| TATA: -0.02 (NI 4.58b - CFO 5.62b) / TA 58.33b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of CRH shares?
As of March 31, 2026, the stock is trading at USD 101.91 with a total of 5,563,123 shares traded.
Over the past week, the price has changed by -2.40%, over one month by -14.76%, over three months by -18.71% and over the past year by +17.50%.
Over the past week, the price has changed by -2.40%, over one month by -14.76%, over three months by -18.71% and over the past year by +17.50%.
Is CRH a buy, sell or hold?
CRH has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy CRH.
- StrongBuy: 14
- Buy: 5
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRH price?
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 142.4 | 39.7% |
| Analysts Target Price | 142.4 | 39.7% |
CRH Fundamental Data Overview
March 28, 2026
P/E Trailing = 18.7296 P/E Forward = 17.0068
P/S = 1.843
P/B = 2.8006
P/EG = 2.0001
Revenue TTM = 49.18b USD
EBIT TTM = 6.69b USD
EBITDA TTM = 9.69b USD
Long Term Debt = 16.48b USD (from longTermDebt, last quarter)
Short Term Debt = 1.58b USD (from shortTermDebt, last quarter)
Debt = 19.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.61b USD (from netDebt column, last quarter)
Enterprise Value = 84.62b USD (69.01b + Debt 19.70b - CCE 4.10b)
Interest Coverage Ratio = 6.28 (Ebit TTM 6.69b / Interest Expense TTM 1.07b)
EV/FCF = 29.06x (Enterprise Value 84.62b / FCF TTM 2.91b)
FCF Yield = 3.44% (FCF TTM 2.91b / Enterprise Value 84.62b)
FCF Margin = 5.92% (FCF TTM 2.91b / Revenue TTM 49.18b)
Net Margin = 9.32% (Net Income TTM 4.58b / Revenue TTM 49.18b)
Gross Margin = 35.62% ((Revenue TTM 49.18b - Cost of Revenue TTM 31.66b) / Revenue TTM)
Gross Margin QoQ = 34.88% (prev 38.93%)
Tobins Q-Ratio = 1.45 (Enterprise Value 84.62b / Total Assets 58.33b)
Interest Expense / Debt = 2.63% (Interest Expense 518.7m / Debt 19.70b)
Taxrate = 20.03% (523.2m / 2.61b)
NOPAT = 5.35b (EBIT 6.69b * (1 - 20.03%))
Current Ratio = 1.74 (Total Current Assets 15.25b / Total Current Liabilities 8.75b)
Debt / Equity = 0.82 (Debt 19.70b / totalStockholderEquity, last quarter 24.00b)
Debt / EBITDA = 1.61 (Net Debt 15.61b / EBITDA 9.69b)
Debt / FCF = 5.36 (Net Debt 15.61b / FCF TTM 2.91b)
Total Stockholder Equity = 20.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.55% (Net Income 4.58b / Total Assets 58.33b)
RoE = 22.33% (Net Income TTM 4.58b / Total Stockholder Equity 20.53b)
RoCE = 18.09% (EBIT 6.69b / Capital Employed (Equity 20.53b + L.T.Debt 16.48b))
RoIC = 13.50% (NOPAT 5.35b / Invested Capital 39.65b)
WACC = 9.12% (E(69.01b)/V(88.72b) * Re(11.12%) + D(19.70b)/V(88.72b) * Rd(2.63%) * (1-Tc(0.20)))
Discount Rate = 11.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.31%
[DCF] Terminal Value 71.22% ; FCFF base≈2.66b ; Y1≈2.23b ; Y5≈1.66b
[DCF] Fair Price = 14.53 (EV 25.33b - Net Debt 15.61b = Equity 9.72b / Shares 668.7m; r=9.12% [WACC]; 5y FCF grow -19.65% → 3.0% )
EPS Correlation: 0.46 | EPS CAGR: -37.13% | SUE: 1.51 | # QB: 1
Revenue Correlation: 6.29 | Revenue CAGR: 14.69% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.14 | Chg7d=-0.003 | Chg30d=+0.025 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=5.98 | Chg7d=+0.002 | Chg30d=+0.015 | Revisions Net=-4 | Growth EPS=+6.5% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=6.66 | Chg7d=+0.017 | Chg30d=+0.045 | Revisions Net=-5 | Growth EPS=+11.1% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 11.1% - Earnings Yield 5.3%)
[Growth] Growth Spread = -1.0% (Analyst 4.8% - Implied 5.8%)